|
Inotiv Inc (NASDAQ: NOTV) |
|
Inotiv Inc
NOTV's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Inotiv Inc 's sales fell
by -14.82 % in I. Quarter 2024 from the same quarter a year ago.
Ranking at No. 532
Medical Laboratories industry recorded
growth of revenues by 6.35 %
Inotiv Inc net loss increased from $-12 millions, to $-28 millions in I. Quarter 2024,
• More on NOTV's Growth
|
|
Inotiv Inc realized a net loss in trailing twelve months.
Inotiv Inc realized cash reduction of $ -0.16 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
-0 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.11.
Medical Laboratories industry's Price to Sales ratio is at 2.17.
• More on NOTV's Valuation
|
|
|
|
|
Inotiv Inc realized net loss in trailing twelve months.
Inotiv Inc realized cash outflow of $ -0.16per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
-0 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.11.
Medical Laboratories industry's Price to Sales ratio is at 2.17.
Inotiv Inc Price to Book Ratio is at 0.3 lower than Industry Avg. of 147.07. and higher than S&P 500 Avg. of 0.01
• More on NOTV's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com